10 Best New Stocks to Buy With Huge Upside Potential
On June 15, Ed Yardeni, Yarden Research President, appeared on CNBC's 'Squawk Box' to discuss the latest market trends.
Telix Pharmaceuticals Ltd (TLX)
Market is closed
Sector: Healthcare
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.87 | 33,435 | $497,178.45 | 20,742,935 | 2026-04-29 | Filing | |
| $14.48 | 34,500 | $499,560.00 | 20,709,500 | 2026-04-28 | Filing |
News See All
8 Best Australian Stocks to Buy in 2026
The Australian stock market has been extremely volatile in line with other global equity indexes.
10 Overlooked Growth Stocks to Buy Now
On April 14, Tom Lee, Fundstrat's Head of Research, joined CNBC's 'Power Lunch' to discuss his outlook on equities.
Wall Street Bullish on Telix Pharmaceuticals (TLX), Here's Why
Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the Best All-Time Low Stocks to Invest In Now.
12 Best All-Time Low Stocks to Invest In Now
On February 24, Paul Christopher, Wells Fargo's head of global market strategy, appeared on a CNBC television interview to discuss market outlooks.
Telix Pharmaceuticals Limited (NASDAQ:TLX) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Telix Full Year 2025 Results and Investor Webcast.
12 Stocks that Will Bounce Back According to Wall Street Analysts
On January 5, Reuters reported that many analysts believe global investors will actively look for opportunities in undervalued areas of the financial markets in 2026.
Telix Pharmaceuticals Limited (TLX)’s Commercial Progress Meets a Cautious Outlook
Telix Pharmaceuticals Limited (NASDAQ:TLX) is among the best NASDAQ stocks under $10 to buy.
10 Best NASDAQ Stocks Under $10 to Buy
As retail participation in equity markets continues to expand, investor interest is increasingly shifting toward lower-priced stocks and companies outside the traditional mega-cap universe.
Telix Pharma (TLX) Makes Progress With New Study
Telix Pharmaceuticals Limited (NASDAQ:TLX) is a biotechnology company developing treatments for ailments such as prostate and kidney cancer.
Hedge Fund Resource Center